{
    "nct_id": "NCT00539305",
    "title": "Testosterone Supplementation in Men With MCI",
    "status": "COMPLETED",
    "last_update_time": "2014-07-10",
    "description_brief": "The purpose of this study is to examine the effects of testosterone (T) replacement on changes in thinking and memory, as well as mood in older men with mild cognitive impairment (MCI) and low T levels. The study will also examine whether taking testosterone has effects on biological markers related to Alzheimer's disease.",
    "description_detailed": "Natural age related declines in testosterone (T) are associated with decreases in cognitive abilities independent of health status. Low T levels over time are associated with increased risk for developing Alzheimer's disease (AD). These findings suggest that men with low T levels are most at risk for age-related cognitive decline and AD and therefore most likely to benefit from T supplementation to prevent the development of AD or age-associated cognitive decline. The current study will assess cognition, mood, and cerebral spinal fluid (CSF) biomarker response to T supplementation in older men with mild cognitive impairment (MCI) and low T levels.\n\nParticipants will be randomized to either receive T treatment or a placebo for six months. Participants will come in for about five visits within the span of six months where they will complete cognitive \\& memory tests, fill out mood questionnaires, and have their blood drawn to monitor the medication level. A sample of blood will also be taken at one visit to test for apolipoprotein E (APOE), which is a genetic risk factor associated with AD. Participants will have the option to get a spinal tap in order to measure biological markers associated with Alzheimer's disease including beta-amyloid 1-40, 42, total-tau, and phosphorylated-tau-181-231. This will require an additional two visits.",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Treatment Group",
                    "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months"
                },
                {
                    "id": "FG001",
                    "title": "Placebo Group",
                    "description": "Placebo gel : applied topically daily for six months"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "12"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "9"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "10"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Substance Use",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Treatment Group",
                    "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months"
                },
                {
                    "id": "BG001",
                    "title": "Placebo Group",
                    "description": "Placebo gel : applied topically daily for six months"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "10"
                        },
                        {
                            "groupId": "BG001",
                            "value": "12"
                        },
                        {
                            "groupId": "BG002",
                            "value": "22"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "6"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "71.2",
                                            "spread": "9.1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "70.0",
                                            "spread": "7.7"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "70.5",
                                            "spread": "8.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Behavioral & Mood Measure: Profile of Mood States (POMS)",
                    "description": "Values represent self evaluation of vigor-activity. The scale compares t-scores of participants to published norms (range 0-100), and higher scores indicate elevated emotion in subscale. Higher t-scores in vigor-activity subscale are considered favorable. Month 3 and Month 6 values display change from baseline.",
                    "populationDescription": "Vigor-Activity",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline, 3 and 6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Treatment Group",
                            "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Group",
                            "description": "Placebo gel : applied topically daily for six months"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "9"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "57.7",
                                            "spread": "2.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "55.5",
                                            "spread": "2.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 3 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-4.5",
                                            "spread": "2.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.1",
                                            "spread": "2.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 6 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.9",
                                            "spread": "2.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.5",
                                            "spread": "2.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Cognitive Changes Measured by Neuropsychological Tests: Rey Auditory Verbal Learning Test",
                    "description": "Values represent total score in Long Delay Word List Recall. Higher score indicates higher level of functioning (range 0-15). Month 3 and Month 6 indicate change from baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline, 3 and 6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Treatment Group",
                            "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Group",
                            "description": "Placebo gel : applied topically daily for six months"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "9"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.2",
                                            "spread": "1.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.9",
                                            "spread": "1.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 3 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.3",
                                            "spread": "0.9"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.0",
                                            "spread": "0.8"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 6 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.9",
                                            "spread": "0.9"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.5",
                                            "spread": "0.8"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Geriatric Depression Scale (GDS)",
                    "description": "Values represent self evaluation of depression (range 0-30). Higher scores indicate a more depressed mood. Month 3 and Month 6 indicate change from baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline, Month 3, Month 6",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Treatment Group",
                            "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Group",
                            "description": "Placebo gel : applied topically daily for six months"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "9"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "7.2",
                                            "spread": "1.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.1",
                                            "spread": "1.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 3 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.7",
                                            "spread": "1.5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.3",
                                            "spread": "1.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 6 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.8",
                                            "spread": "1.5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.7",
                                            "spread": "2.3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Short-Form Health Survey (SF-36)",
                    "description": "Self assessment of Physical Functioning in Health Survey. Higher scores indicate a higher level of functioning (range 0-100). Month 3 and 6 values represent change from baseline in subscale.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline, Month 3, Month 6",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Treatment Group",
                            "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo Group",
                            "description": "Placebo gel : applied topically daily for six months"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "9"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "70.7",
                                            "spread": "10.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "85.6",
                                            "spread": "2.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 3 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "15.0",
                                            "spread": "9.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-3.8",
                                            "spread": "6.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Month 6 (Change from Baseline)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.4",
                                            "spread": "8.6"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-5.4",
                                            "spread": "3.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Treatment Group",
                    "description": "Dose will be adjusted as needed to maintain a target total T level of 500-900 ng/dl\n\ntestosterone gel : 50-100mg applied topically daily for six months",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 10,
                    "otherNumAffected": 2,
                    "otherNumAtRisk": 10
                },
                {
                    "id": "EG001",
                    "title": "Placebo Group",
                    "description": "Placebo gel : applied topically daily for six months",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 12,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 12
                }
            ],
            "otherEvents": [
                {
                    "term": "PSA elevated above 4.0 ng/ml",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        }
                    ]
                },
                {
                    "term": "Emergency room with chest pains",
                    "organSystem": "General disorders",
                    "notes": "Pain stopped within 10-15 minutes, patient was not admitted to hospital and is following up with his personal physician.",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Monique Cherrier PhD.",
                "organization": "University of Washington",
                "email": "cherrier@u.washington.edu",
                "phone": "206-277-3594"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "testosterone (androgen replacement therapy)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests testosterone replacement to improve thinking, memory, and mood in older men with MCI and low testosterone; it also measures effects on Alzheimer\u2019s-related biomarkers. This framing (improving cognition/mood) is consistent with a cognitive-enhancer intent rather than a therapy designed to directly clear amyloid or tau. \ue200cite\ue202turn0search3\ue201",
        "Act: Intervention identified \u2014 testosterone. Testosterone is a steroid androgen used for replacement therapy and is classified as a small-molecule androgen receptor agonist (not a biologic). Mechanistic summaries: DrugBank lists testosterone as a small-molecule androgen acting via the androgen receptor, and clinical references describe classical and non-classical androgen actions and its metabolism (DHT/aromatization). \ue200cite\ue202turn1search1\ue202turn1search4\ue201",
        "Supporting trial context / prior evidence: Published trials of testosterone in men with MCI or age-associated memory impairment show mixed, generally modest and domain-limited cognitive/mood effects (some improvement in verbal or spatial memory or mood in small trials; larger/longer trials often show no robust benefit). This supports classification as a cognitive/symptom-focused intervention rather than a disease-modifying anti-amyloid/tau biologic. \ue200cite\ue202turn0search2\ue202turn0search4\ue201",
        "Reflect: Although the study measures Alzheimer\u2019s biomarkers, the drug itself (testosterone) is not a biologic targeting canonical AD pathology (amyloid or tau) and is used here to attempt to improve cognition/mood in hypogonadal men. Therefore the best-fit category is 'cognitive enhancer'. Note ambiguity: if future evidence showed primary disease-modifying effects on AD pathology, classification could shift, but based on the trial description and testosterone\u2019s mechanism the cognitive enhancer category is appropriate. \ue200cite\ue202turn0search3\ue202turn1search1\ue201"
    ],
    "agent_type": "L) Growth Factors and Hormones",
    "explanation_agent": [
        "Reason: The intervention is testosterone replacement intended to improve cognition/mood in men with MCI; testosterone acts biologically as a steroid hormone/androgen that signals via the androgen receptor rather than directly targeting amyloid or tau pathology. \ue200cite\ue202turn0search3\ue201",
        "Act: Extracted details \u2014 drug: testosterone (androgen replacement therapy). Mechanism: small-molecule/steroid hormone that is an androgen receptor (AR) agonist (ligand-activated nuclear receptor/transcription factor). Clinical trials in MCI/older men have shown mixed and generally modest, domain-limited cognitive or mood effects (examples: a small randomized IM-T enanthate study with spatial memory benefit; a 6-month RCT in men with MCI/low T with modest verbal memory and mood effects), and systematic reviews/meta-analyses find small or inconsistent cognitive benefits. \ue200cite\ue202turn0search3\ue202turn0search1\ue202turn0search4\ue202turn0search5\ue201",
        "Reflect: CADRO classification is based on the biological target/pathway. Because testosterone is a hormone acting via androgen receptor signaling, the most specific CADRO match is L) Growth Factors and Hormones. The trial\u2019s intent as a \"cognitive enhancer\" describes clinical purpose, but the underlying target is hormonal (not amyloid, tau, inflammation, etc.), so 'L) Growth Factors and Hormones' is the appropriate category. If the intervention were primarily designed to modify canonical AD pathology (amyloid or tau) the classification would differ, but the provided description and mechanism support L. \ue200cite\ue202turn0search3\ue202turn0search5\ue201"
    ]
}